78.8
Alaunos Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
53.8
FY23:
8.26
FY24:
2.76
FY25:
1.99
(positive)
Change from FY21 to FY25
millions USD
FY21:
16.0
FY22:
11.1
FY23:
0.00
FY24:
0
FY25:
0.98
Total assets
Change from FY21 to FY25
millions USD
FY21:
94.9
FY22:
64.9
FY23:
8.26
FY24:
2.76
FY25:
2.97
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
16.0
FY22:
24.2
FY23:
1.96
FY24:
0.69
FY25:
0.81
(negative)
Change from FY21 to FY25
millions USD
FY21:
20.8
FY22:
2.22
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
58.1
FY22:
38.6
FY23:
6.31
FY24:
2.06
FY25:
2.15
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
94.9
FY22:
64.9
FY23:
8.26
FY24:
2.76
FY25:
2.97
All amounts in millions USD